Search results
Results From The WOW.Com Content Network
Beclometasone or beclomethasone, also known as beclomethasone dipropionate, and sold under the brand name Qvar among others, is a steroid medication. [1] It is available as an inhaler, cream, pills, and nasal spray. [2] The inhaled form is used in the long-term management of asthma. [1] The cream may be used for dermatitis and psoriasis. [3]
This multi-page article lists pharmaceutical drugs alphabetically by name. Many drugs have more than one name and, therefore, the same drug may be listed more than once. ...
Antenatal steroids have also been shown to have definite beneficial effect in treating the condition of preterm premature rupture of membranes (PPROM). [8] Similar to its effects on preterm birth, research evidence suggests that the administration of antenatal steroids to patients with PPROM reduces risks of neonatal mortality, intraventricular hemorrhage and respiratory distress syndrome.
Pregnancy-related anxiety is a distinct anxiety contextualized by pregnancy specific fears, worries, and concerns. [ 1 ] [ 2 ] Pregnancy-related anxiety is characterized by increased concerns or excessive fears and worries about their unborn baby, childbirth , body image , and impending motherhood.
Very long duration of action (12–24 hours) Huge improvement in lung function and symptoms; Risk of exacerbation greatly lowered → LAMA more prominent than LABA; Provided in inhalers → techniques for usage is important for management of COPD [31] Caution [28] Should not be used in acute exacerbation for rapid relieve of symptoms
The duration is remarkably short, with a median duration of 8 days. This, together with the absence of a family history and of recurrences, contrasts with puerperal bipolar/cycloid psychoses. After recovery, amnesia and sometimes retrograde memory loss may occur, as well as other permanent cerebral lesions such as dysphasia, hemiplegia or ...
In 2007 and 2008, studies were conducted on quetiapine's efficacy in treating generalized anxiety disorder and major depression. Patent protection for the product ended in 2012; however, in a number of regions, the long-acting version remained under patent until 2017.
Milnacipran should not be used during pregnancy because it may cross the placenta barrier and no clinical data exists on harmful effects in humans and animal studies. Milnacipran is contraindicated during lactation because it is excreted in the milk, and it is not known if it is harmful to the newborn.